VR Logo

Regeneron Pharmaceuticals Inc. (REGN) download report


Healthcare | Biotechnology & Pharma Research

Regeneron Pharmaceuticals Inc. (REGN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

IPO Date: 02-Apr-1991

Founder, Pres, CEO & Director: Dr. Leonard S. Schleifer M.D., Ph.D.

Scientific Founder, Pres, Chief Scientific Officer & Director: Dr. George D. Yancopoulos M.D., Ph.D.

Listing: NASDAQ: REGN

Country: United States

Headquarters: Tarrytown, NY

Website: https://www.regeneron.com

Key Facts

Market cap: $69,209.18 Mln

Revenue (TTM): $16,508.10 Mln

Earnings (TTM): $7,933.60 Mln

Cash: $7,050.60 Mln

Total Debt: $2,700.40 Mln

Insider's Holding: 2.69%

Liquidity: Low

52 Week range: $538.01 - 747.42

Shares outstanding: 108,028,000

10 Years Aggregate:

  • CFO: $19,687.98 Mln
  • EBITDA: $26,340.57 Mln
  • Net Profit: $20,401.49 Mln

Stock Performance

Time Period Regeneron Pharmaceuticals (REGN) S&P BSE Sensex S&P 100
YTD-0.442.08-11.04
1 month2.329.3210.75
3 months2.559.948.84
1 Year3.339.05-4.00
3 Years27.2816.5314.88
5 Years6.1513.7612.53
10 Years16.4712.9711.69
As on 12-Aug-2022
Year Regeneron Pharmaceuticals (REGN) S&P 100 S&P BSE Sensex
202130.7227.5521.99
202028.6619.3015.75
20190.5329.4714.38
2018-0.65-5.825.87
20172.4219.3427.91
2016-32.388.781.95
201532.330.34-5.03